贊宇科技(002637.SZ):擬設立杭州贊宇 有助於拓展表面活性劑、日用化工、油脂化工領域的業務範圍
格隆匯 11 月 30日丨贊宇科技(002637.SZ)公佈,根據公司的戰略佈局,公司擬以自籌資金設立全資子公司杭州贊宇科技有限公司(“杭州贊宇”,暫定名,以工商部門名稱登記為準),擬設立的全資子公司註冊資本為1億元。
該公司經營範圍:研發、製造、銷售:表面活性劑、日用化工產品、化粧品、工業清洗劑、油脂化學品、樹脂、熱熔膠、工業用油脂、洗滌用品、輕紡產品、化工產品(以上經營項目危險、劇毒除外);貨物進出口;技術開發、技術轉讓、技術諮詢及配套工程服務,技術進出口。
此次設立杭州贊宇有助於公司拓展表面活性劑、日用化工、油脂化工領域的業務範圍,優化公司的戰略佈局,有利於進一步提升公司的綜合競爭力,實現公司的可持續發展。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.